All Categories

Prevalence of variants in methylenetetrahydrofolate reductase and the severity of pulmonary vascular disease

Ronald W. Day, Gordon K. Mack, Andrea M. Barker, Tiffany Q. Rees, Lynda O. Jorgensen, Lorenzo D. BottoUniversity of Utah and Primary Children’s HospitalUnited States Pediatric CardiologyPediatr Cardiol 2015; 36: 524-530DOI: 10.1007/s00246-014-1044-x AbstractPulmonary hypertension is a serious disease associated with constriction, cellular proliferation, inflammation, and in situ thrombosis of the small vessels of the lung. Some […]

Prevalence of variants in methylenetetrahydrofolate reductase and the severity of pulmonary vascular disease Read More »

A long-term survivor with alveolar capillary dysplasia

Chandler E. Yost, Angelica R. Putnam, Megan K. Dishop, Lynda O. Jorgenson, Paul E. Wirkus, Ronald W. DayUniversity of Utah, Primary Children’s Hospital, Phoenix Children’s Hospital and Wasatch PediatricsUnited States Journal of the American College of Cardiology Case ReportsJACC Case Rep 2020; 2: 1492-1495DOI: 10.1016/j.jaccas.2020.05.055 AbstractA patient with alveolar capillary dysplasia has survived more than 56

A long-term survivor with alveolar capillary dysplasia Read More »

Improving guidance for the correctability of congenital shunts with increased pulmonary vascular resistance

Ronald W. DayUniversity of Utah and Primary Children’s HospitalUnited States International Journal of Cardiology Congenital Heart DefectsInt J Cardiol Congenit Heart Dis 2021;doi.org/10.1016/j.ijcchd.2021.100184 AbstractBackground. Based upon expert opinion, guidelines have been proposed for the correctability of congenital cardiovascular shunts with increased pulmonary vascular resistance. This study reports the accuracy of published guidelines using a dataset

Improving guidance for the correctability of congenital shunts with increased pulmonary vascular resistance Read More »

Scroll to Top